MUC21 is downregulated in oral squamous cell carcinoma and associated with poor prognosis
Frontiers in Oncology · 25.03.2026 · 16
DOI: 10.3389/fonc.2026.1767261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 25.03.2026. Verfasst von Lisha Mao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Plastic and Trauma Surgery, Capital Medical University School of Stomatology, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although mucins are generally linked to aggressive tumor behavior and poor clinical outcomes, the role of MUC21 in oral squamous cell carcinoma (OSCC) remains unexplored. Previous in vitro studies suggest that MUC21 may inhibit cancer cell adhesion, indicating its potential significance in OSCC pathogenesis.
Methods
We analyzed microarray data from 10 OSCC tissues and paired adjacent normal tissues (para-OSCC), along with GEO and TCGA RNA-seq datasets, to identify differentially expressed genes, including MUC21. qRT-PCR was performed to validate MUC21 expression and its co-expressed epithelial differentiation-related genes. Additionally, immunohistochemistry (IHC) on 102 paired OSCC/para-OSCC samples assessed the correlation between MUC21 expression and clinical outcomes. In vitro functional assays (CCK-8, wound healing, Transwell) were conducted using OSCC cell lines (CAL27, HN6) with MUC21 overexpression or knockdown.
Results
MUC21 was significantly downregulated in OSCC compared to normal tissue, supported by high-throughput datasets, qRT-PCR, and IHC. We identified 11 co-expressed genes, including epithelial differentiation markers (KRT4, KRT13, CRNN), which were further validated. Low MUC21 expression correlated with pathological lymph node metastasis, poor tumor differentiation, and reduced survival. Furthermore, MUC21 Knockdown significantly increased cell proliferation, migration and invasion in OSCC cell lines and vice versa.
Conclusion
MUC21 downregulation is associated with reduced epithelial differentiation, increased clinical aggressiveness, and worse prognosis in OSCC. MUC21 may serve as a novel prognostic biomarker and tumor suppressor gene in OSCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Plastic and Trauma Surgery, Capital Medical University School of Stomatology, Beijing, China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Disease, The Fourth Military Medical University, Xi'an, China.
- Shaanxi Key Laboratory of Stomatology, Department of Oral Biology & Clinic of Oral Rare Diseases and Genetic Diseases, School of Stomatology, Xi'an, China.
- Beijing Institute of Dental Research, Capital Medical University School of Stomatology, Beijing, China.
Zitieren
APA
Mao, L., Kang, J., Zou, A., Wang, X., Guo, S., Chen, S., Su, Y., Ge, L., Yang, J., & Wang, X. (2026). MUC21 is downregulated in oral squamous cell carcinoma and associated with poor prognosis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1767261
Vancouver
Mao L, Kang J, Zou A, Wang X, Guo S, Chen S, et al. MUC21 is downregulated in oral squamous cell carcinoma and associated with poor prognosis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1767261
BibTeX
@article{Mao2026,
author = {Mao, Lisha and Kang, Jia and Zou, Anna and Wang, Xiangpu and Guo, Siyuan and Chen, Sijia and Su, Ying and Ge, Lihua and Yang, Jing and Wang, Xuejiu},
title = {MUC21 is downregulated in oral squamous cell carcinoma and associated with poor prognosis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1767261}
}
EUVIMED